Company Filing History:
Years Active: 2018-2019
Title: The Innovative Contributions of Moreno Wichert
Introduction
Moreno Wichert is a notable inventor based in Wangen-Nuolen, Switzerland. With a focus on the synthesis of nucleic acid-encoded chemical libraries and targeted therapeutic agents, Wichert has made significant strides in the field of chemical and pharmaceutical innovations. He holds a total of 3 patents, showcasing his commitment to advancing scientific knowledge and technology.
Latest Patents
One of Wichert's latest patents is related to the production of encoded chemical libraries. This invention involves the synthesis of nucleic acid-encoded chemical libraries using common adaptor sequences. Nucleic acid strands coupled to chemical moieties are contacted with identifier oligonucleotides that comprise coding sequences. This allows for the ligation of identifier oligonucleotides to the nucleic acid strands, facilitating the production and screening of these libraries.
Another significant patent focuses on small molecule drug conjugates. This invention includes a binding moiety for Carbonic Anhydrase IX (CAIX), which can be univalent, bivalent, or multivalent. The targeted therapeutic agent developed from this binding moiety aims to treat diseases that express elevated levels of CAIX, demonstrating Wichert's dedication to addressing critical health challenges.
Career Highlights
Throughout his career, Moreno Wichert has worked with esteemed organizations such as ETH Zurich and Philochem AG. His experience in these institutions has contributed to his expertise in the field of chemical and pharmaceutical research.
Collaborations
Wichert has collaborated with notable colleagues, including Willy Decurtins and Dario Neri. These partnerships have likely enriched his research and innovation efforts, fostering a collaborative environment for scientific advancement.
Conclusion
Moreno Wichert's contributions to the field of chemical libraries and targeted therapies highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a deep understanding of complex scientific principles and a commitment to advancing technology in meaningful ways.